We are live on ! Find out more
SMIHW

Summit Healthcare Acquisition Corp. Warrant
SMIHW

Delisted

SMIHW was delisted on the 16th of March, 2023.

Back to rankings

23 hedge funds and large institutions have $19.2M invested in Summit Healthcare Acquisition Corp. Warrant in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more capital invested

Capital invested by funds: $13.1M → $19.2M (+$6.14M)

4% less funds holding

Funds holding: 24 → 23 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

Holders
23
Holders Change
-1
Holders Change %
-4.17%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
–
Closed
4
Calls
$130K
Puts
–
Net Calls
+$130K
Net Calls Change
+$64K

Top Buyers

Rank Fund Capital Flow
1
Calamos Advisors
Calamos Advisors
Illinois
+$12.9K
2
PC
Periscope Capital
Ontario, Canada
+$9.08K
3
Walleye Capital
Walleye Capital
New York
+$5.91K
4
BCM
Basso Capital Management
Connecticut
+$4.41K
5
MC
Meteora Capital
Florida
+$1.18K

Top Sellers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
-$15K
2
WAM
Weiss Asset Management
Massachusetts
-$12K
3
OMC
Old Mission Capital
Illinois
-$1K
4
MF
Magnetar Financial
Illinois
-$3
Name Holding Trade Value Shares
Change 		Change in
Stake
LP
1
LMR Partners
United Kingdom
$10.2M – – –
SCM
2
Segantii Capital Management
Hong Kong
$5.89M – – –
AC
3
Athos Capital
Hong Kong
$1.47M – – –
RCM
4
Radcliffe Capital Management
Pennsylvania
$982K – – –
BFM
5
Boothbay Fund Management
New York
$287K – – –
FC
6
Finepoint Capital
Massachusetts
$74K – – –
PC
7
Periscope Capital
Ontario, Canada
$37K +$9.08K +103,100 +71%
TAM
8
TFG Asset Management
Cayman Islands
$28K – – –
DACS
9
Dymon Asia Capital (Singapore)
Singapore
$23K – – –
OCM
10
Ovata Capital Management
Hong Kong
$23K – – –
Calamos Advisors
11
Calamos Advisors
Illinois
$22K +$12.9K +146,040 New
QGA
12
Q Global Advisors
Texas
$20K – – –
WA
13
Whitebox Advisors
Minnesota
$19K – – –
AA
14
AQR Arbitrage
Connecticut
$15K – – –
D.E. Shaw & Co
15
D.E. Shaw & Co
New York
$15K – – –
SCM
16
Saba Capital Management
New York
$15K – – –
SCM
17
Shaolin Capital Management
Florida
$15K – – –
Walleye Capital
18
Walleye Capital
New York
$15K +$5.91K +67,105 +205%
BCM
19
Basso Capital Management
Connecticut
$8K +$4.41K +50,000 New
PCM
20
Prelude Capital Management
New York
$4K – – –
MC
21
Meteora Capital
Florida
$2K +$1.18K +13,440 New
AA
22
Ancora Advisors
Ohio
$1K – – –
CS
23
Clear Street
New York
$1K – – –
WP
24
Woodline Partners
California
– -$15K -183,800 Closed
WAM
25
Weiss Asset Management
Massachusetts
– -$12K -100,000 Closed
1
2

SMIHW Hedge Fund Activity: Q3 2022 in Review

23 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Summit Healthcare Acquisition Corp. Warrant (SMIHW) for Q3 2022, worth a combined $19.2M — up 47% from $13.1M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of SMIHW and 3 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 2 added.

The largest buyer was Calamos Advisors, opening a new position worth an estimated $12.9K. The largest seller was Woodline Partners, exiting entirely with an estimated $15K sold.

  • 23 institutional investors held Summit Healthcare Acquisition Corp. Warrant (SMIHW) as of Q3 2022, down from 24 in Q2 2022.
  • Funds reported $19.2M of Summit Healthcare Acquisition Corp. Warrant stock for Q3 2022, up 47% quarter-over-quarter.
  • 3 funds opened new Summit Healthcare Acquisition Corp. Warrant positions in Q3 2022 and 4 closed out, a net change of -1 holder.
  • The largest Summit Healthcare Acquisition Corp. Warrant buyer in Q3 2022 was Calamos Advisors, an estimated $12.9K added.
  • The largest Summit Healthcare Acquisition Corp. Warrant seller in Q3 2022 was Woodline Partners, an estimated $15K sold.

Based on aggregated 13F filings for Q3 2022.